Howard Griffith actually said...

"And I would just ask, in relationship to 503A, because we were talking about it earlier, if that didn't contemplate office use, then why has FDA allowed it up until this point in time?"

"I think sometimes we are talking at cross-purposes because I don't think any of us want to see somebody like NECC coming back."

"As Ms. DeGette said, there has got to be a balance."

"And I disagree, just based on the debate that we had when we were doing this a number of years ago in 2013, because we anticipated there would be continued office use."